Methotrexat Ebewe

Methotrexate, the active ingredient in Methotrexat Ebewe, is an antimetabolite (folate antagonist) presented as a tablet for oral use. It is used to treat rheumatoid arthritis, psoriasis, and certain cancers such as acute lymphoblastic leukemia, non‑Hodgkin lymphoma, and breast cancer.

GNH USA supplies Methotrexat Ebewe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Methotrexat Ebewe is employed in the management of autoimmune diseases and specific malignancies where folate metabolism is a therapeutic target. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: diminishes skin plaque formation and severity. - Acute lymphoblastic leukemia: interferes with malignant cell proliferation. - Non‑Hodgkin lymphoma: impedes growth of lymphoma cells. - Breast cancer: used as part of combination chemotherapy to limit tumor growth.

Methotrexat Ebewe may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea and vomiting - Fatigue or weakness - Oral mucosal ulceration (mouth sores) - Transient elevation of liver enzymes - Mild alopecia (hair thinning) - Low white blood cell count (leukopenia)

Serious or Rare Side Effects: - Severe hepatotoxicity or liver fibrosis - Pulmonary fibrosis or interstitial pneumonitis - Profound bone marrow suppression leading to pancytopenia - Acute renal failure - Life‑threatening cutaneous reactions (e.g., Stevens‑Johnson syndrome) - Opportunistic infections due to immunosuppression

When prescribing Methotrexat Ebewe, clinicians should observe several safety considerations. - Pregnancy: contraindicated (Category X) – avoid use in pregnant women. - Renal function: assess before initiation and monitor regularly. - Liver function: baseline tests required; monitor for hepatotoxicity. - Hematologic status: monitor blood counts for myelosuppression. - Drug interactions: avoid concomitant use with high‑dose NSAIDs and certain antibiotics. - Store at ambient temperature: keep below 25 °C, in original packaging, protect from moisture and light.

Methotrexat Ebewe interacts with several medicines that can alter its efficacy or safety profile.

Major Interactions (Avoid): - Live vaccines: increased risk of severe infection. - Azathioprine or other immunosuppressants: additive bone‑marrow suppression. - High‑dose NSAIDs: may increase methotrexate toxicity.

Moderate Interactions (Monitor Closely): - Trimethoprim‑sulfamethoxazole: may enhance myelosuppression. - Penicillins: can reduce renal clearance of methotrexate. - Proton pump inhibitors: may affect absorption. - Alcohol: can exacerbate hepatotoxicity.